Cargando…

Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses

Smart conductive materials are developed in regenerative medicine to promote a controlled release profile of charged bioactive agents in the vicinity of implants. The incorporation and the active electrochemical release of the charged compounds into the organic conductive coating is achieved due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez Sánchez, Karla, Ledezma-Espinoza, Aura, Sánchez-Kopper, Andrés, Avendaño-Soto, Esteban, Prado, Mónica, Starbird Perez, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249122/
https://www.ncbi.nlm.nih.gov/pubmed/32375224
http://dx.doi.org/10.3390/molecules25092139
_version_ 1783538530971025408
author Ramírez Sánchez, Karla
Ledezma-Espinoza, Aura
Sánchez-Kopper, Andrés
Avendaño-Soto, Esteban
Prado, Mónica
Starbird Perez, Ricardo
author_facet Ramírez Sánchez, Karla
Ledezma-Espinoza, Aura
Sánchez-Kopper, Andrés
Avendaño-Soto, Esteban
Prado, Mónica
Starbird Perez, Ricardo
author_sort Ramírez Sánchez, Karla
collection PubMed
description Smart conductive materials are developed in regenerative medicine to promote a controlled release profile of charged bioactive agents in the vicinity of implants. The incorporation and the active electrochemical release of the charged compounds into the organic conductive coating is achieved due to its intrinsic electrical properties. The anti-inflammatory drug dexamethasone was added during the polymerization, and its subsequent release at therapeutic doses was reached by electrical stimulation. In this work, a Poly (3,4-ethylenedioxythiophene): κ-carrageenan: dexamethasone film was prepared, and κ-carrageenan was incorporated to keep the electrochemical and physical stability of the electroactive matrix. The presence of κ-carrageenan and dexamethasone in the conductive film was confirmed by µ-Raman spectroscopy and their effect in the topographic was studied using profilometry. The dexamethasone release process was evaluated by cyclic voltammetry and High-Resolution mass spectrometry. In conclusion, κ-carrageenan as a doping agent improves the electrical properties of the conductive layer allowing the release of dexamethasone at therapeutic levels by electrochemical stimulation, providing a stable system to be used in organic bioelectronics systems.
format Online
Article
Text
id pubmed-7249122
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72491222020-06-10 Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses Ramírez Sánchez, Karla Ledezma-Espinoza, Aura Sánchez-Kopper, Andrés Avendaño-Soto, Esteban Prado, Mónica Starbird Perez, Ricardo Molecules Article Smart conductive materials are developed in regenerative medicine to promote a controlled release profile of charged bioactive agents in the vicinity of implants. The incorporation and the active electrochemical release of the charged compounds into the organic conductive coating is achieved due to its intrinsic electrical properties. The anti-inflammatory drug dexamethasone was added during the polymerization, and its subsequent release at therapeutic doses was reached by electrical stimulation. In this work, a Poly (3,4-ethylenedioxythiophene): κ-carrageenan: dexamethasone film was prepared, and κ-carrageenan was incorporated to keep the electrochemical and physical stability of the electroactive matrix. The presence of κ-carrageenan and dexamethasone in the conductive film was confirmed by µ-Raman spectroscopy and their effect in the topographic was studied using profilometry. The dexamethasone release process was evaluated by cyclic voltammetry and High-Resolution mass spectrometry. In conclusion, κ-carrageenan as a doping agent improves the electrical properties of the conductive layer allowing the release of dexamethasone at therapeutic levels by electrochemical stimulation, providing a stable system to be used in organic bioelectronics systems. MDPI 2020-05-03 /pmc/articles/PMC7249122/ /pubmed/32375224 http://dx.doi.org/10.3390/molecules25092139 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ramírez Sánchez, Karla
Ledezma-Espinoza, Aura
Sánchez-Kopper, Andrés
Avendaño-Soto, Esteban
Prado, Mónica
Starbird Perez, Ricardo
Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses
title Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses
title_full Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses
title_fullStr Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses
title_full_unstemmed Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses
title_short Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses
title_sort polysaccharide κ-carrageenan as doping agent in conductive coatings for electrochemical controlled release of dexamethasone at therapeutic doses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249122/
https://www.ncbi.nlm.nih.gov/pubmed/32375224
http://dx.doi.org/10.3390/molecules25092139
work_keys_str_mv AT ramirezsanchezkarla polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses
AT ledezmaespinozaaura polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses
AT sanchezkopperandres polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses
AT avendanosotoesteban polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses
AT pradomonica polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses
AT starbirdperezricardo polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses